$WPC

W. P. Carey Inc. (WPC): Results of Operations and Financial Condition

W. P. Carey Inc. (WPC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 wpc2026q2supplementalexh992.htm EX-99.2 Document Exhibit 99.2 W. P. Carey Inc. Supplemental Information Second Quarter 2026 Terms and Definitions As used in this supplemental package, the terms “W. P. Carey,” “WPC,” “we,” “us” and “our” include W. P. Carey Inc., its con

Original reporting
Published Jul 28, 2026, 8:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 8:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$WPC
Neutral
medium confidence
Mentioned
$WPC
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$WPCNeutralMed
01

Why it matters

Key disclosed metrics include Q2 revenues of $461.1M, net income attributable to WPC of $185.4M, AFFO attributable of $305.4M, and an annualized dividend of $3.76 with a 5.3% yield based on a $71.50 quarter-end share price. Leverage is shown as net debt to adjusted EBITDA (annualized) of 5.5x and net debt to enterprise value of 35.1%.

02

Market read

Provides fresh quarterly operating and leverage datapoints that can affect valuation multiples and dividend sustainability perceptions for income REIT investors.

03

What to watch

Traders may focus on tenant concentration, same-store contractual growth, and debt maturity/interest-rate sensitivity, but those details are only partially visible in the provided excerpt.

Relevance 7/10Novelty 6/10Timing: after-hours filing of Q2 2026 results on SEC EDGAR

Background

The document is W. P. Carey’s SEC Form 8-K Item 2.02 with supplemental information for the quarter ended June 30, 2026.

Company-level read

Ticker impact

$WPCNeutralMedium confidence
Context

W. P. Carey filed an 8-K with Q2 2026 operating results, including revenues, net income, AFFO, and dividend metrics.

Expected impact

Likely modest, with direction dependent on how investors interpret AFFO and leverage versus expectations.

Evidence & confidence

This is a primary-source quarterly results supplement (Item 2.02) with specific figures for AFFO, NOI, payout, and net debt/EBITDA, but the excerpt does not include guidance or a clear surprise versus prior quarters.

Market effects

Adds another data point on net-leased REIT fundamentals, including occupancy, lease term, and leverage ratios that can influence sector risk premia.

No explicit regional macro or property-market shock is disclosed in the excerpt.

Limited, as the filing is company-specific and does not cite cross-border regulatory or capital-market disruptions.

Counterpoint

If the market had already priced in Q2 performance, the incremental impact may be limited because the excerpt lacks any explicit guidance change or standout surprise item.

Key entities

  • W. P. Carey Inc.

    Net-leased REIT reporting Q2 2026 results and balance-sheet metrics via SEC 8-K Item 2.02 supplemental package.

Related articles

$MAAMed

Mid-America Apartment Communities Vs. W.P. Carey: Why One REIT Dividend Claimed 86% Of Core AFFO - W.P.

Mid-America Apartment Communities (MAA) reported Q2 Core AFFO of $1.77 per share, down from $1.85, and kept its quarterly dividend at $1.530. It narrowed full-year Core AFFO guidance to $7.38–$7.62 and said new-lease pricing fell 5.3%. W. P. Carey (WPC) reported Q2 AFFO of $1.34, raised its dividend to $0.940, and lifted/narrowed full-year AFFO guidance to $5.19–$5.27.

Med

Carey Gillam on the Supreme Court’s Decision in the Roundup Case

The US Supreme Court, in a 7-2 ruling in Monsanto v. Durnell, sided with Monsanto, now Bayer, holding that failure-to-warn claims are preempted when the EPA did not require a cancer warning for the pesticide. The decision is expected to limit Roundup-related cancer lawsuits. The article cites Bayer stock up 17% and says Bayer has paid over $11B and is offering $7.25B for class action settlement.

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.

$HLMedAI 8/10

Hecla Mining Q2 Earnings Call Highlights

Hecla Mining reported Q2 financial and operating updates. The company ended the quarter with $483 million cash, about $472 million net cash, and an essentially undrawn $225 million revolver. It projected 2026 free cash flow of about $500 million at $50 silver and $3,500 gold, and raised Greens Creek silver guidance to 8.0-8.3 million ounces. Production guidance was adjusted for Lucky Friday and Keno Hill.

$RCELHighAI 9/10

Avita Medical Shares Surge After Record Second-Quarter Performance

Avita Medical (NASDAQ:RCEL) shares rose about 21.7% in premarket after it reported record Q2 results. Revenue was $21.7M, up 18% YoY and about 8% above estimates. Adjusted loss per share narrowed to $0.25 vs $0.30 expected. Full-year 2026 revenue guidance raised to $86M-$89M and cash-flow breakeven targeted for Q4 2026. BTIG upgraded to Buy with a $7.00 target.